Metastatic cancer of unknown primary in 21 dogs

被引:21
作者
Rossi, F. [1 ]
Aresu, L. [2 ]
Vignoli, M. [1 ]
Buracco, P. [3 ]
Bettini, G. [4 ]
Ferro, S. [2 ]
Gattino, F. [3 ]
Ghiani, F. [5 ]
Costantino, R. [6 ]
Ressel, L. [7 ]
Bellei, E. [8 ]
Marconato, L. [1 ]
机构
[1] Ctr Oncol Vet, Sasso Marconi, Italy
[2] Univ Padua, Dept Comparat Biomed & Nutr, Legnaro, Italy
[3] Sch Vet, Dept Anim Pathol, Grugliasco, Italy
[4] Univ Bologna, Dept Vet Med Sci, Bologna, Italy
[5] Studio Vet Associato Costa Ghiani Spallarossa, Genoa, Italy
[6] Clin Vet Orob, Bergamo, Italy
[7] Diagnost Vet Lab, Sasso Marconi, Italy
[8] Ctr Med Vet, Finale Emilia, Italy
关键词
carcinoma; dog; MCUP; metastatic cancer; prognosis; COOPERATIVE-ONCOLOGY-GROUP; PRIMARY SITE; PRIMARY ORIGIN; PRIMARY-CARCINOMA; TUMORS; MELANOMA; MALIGNANCY; DIAGNOSIS;
D O I
10.1111/vco.12011
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The aim of this retrospective study was to describe clinical features, treatment and outcome of 21 dogs with metastatic cancer of unknown primary (MCUP), a biopsy-proven malignancy being diagnosed at a metastatic stage, in which the anatomical origin of the primary tumour cannot be detected. All dogs underwent total-body computed tomography. Signalment, type and duration of clinical signs, metastasis site, pathology results, treatment and outcome were recorded. Carcinoma was the most common diagnosis (57.1%), followed by sarcoma, melanoma and mast cell tumour. The median number of disease sites per dog was 2, with bones, lymph nodes, lungs and spleen being the most frequent metastatic locations. The median survival for all dogs was 30days. Overall, a primary site was not identified in 20 (95.2%) dogs. MCUP encompasses a variety of different pathologic entities and harbours a poor prognosis.
引用
收藏
页码:11 / 19
页数:9
相关论文
共 30 条
[21]   Cancer of unknown primary: biological and clinical characteristics [J].
Pavlidis, N .
ANNALS OF ONCOLOGY, 2003, 14 :11-18
[22]   Diagnostic and therapeutic management of cancer of an unknown primary [J].
Pavlidis, N ;
Briasoulis, E ;
Hainsworth, J ;
Greco, FA .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (14) :1990-2005
[23]   Carcinoma of unknown primary (CUP) [J].
Pavlidis, Nicholas ;
Fizazi, Karim .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2009, 69 (03) :271-278
[24]   Immunohistochemical detection of uroplakin III, cytokeratin 7, and cytokeratin 20 in canine urothelial tumors [J].
Ramos-Vara, JA ;
Miller, MA ;
Boucher, M ;
Roudabush, A ;
Johnson, GC .
VETERINARY PATHOLOGY, 2003, 40 (01) :55-62
[25]  
Rong R, 2010, INT J CLIN EXP PATHO, V3, P217
[26]   Melanoma without a Detectable Primary Site with Metastases to Lymph Nodes [J].
Rutkowski, Piotr ;
Nowecki, Zbigniew I. ;
Dziewirski, Wirginiusz ;
Zdzienicki, Marcin ;
Pienkowski, Andrzej ;
Salamacha, Maciej ;
Michej, Wanda ;
Trepka, Slawomir ;
Bylina, Elzbieta ;
Ruka, Wlodzimierz .
DERMATOLOGIC SURGERY, 2010, 36 (06) :868-876
[27]  
Schwarz T., 2011, Veterinary computed tomography, P261
[28]   The unknown biology of the unknown primary tumour: a literature review [J].
van de Wouw, AJ ;
Jansen, RLH ;
Speel, EJM ;
Hillen, HFP .
ANNALS OF ONCOLOGY, 2003, 14 (02) :191-196
[29]   SIMPLE PROGNOSTIC MODEL TO PREDICT SURVIVAL IN PATIENTS WITH UNDIFFERENTIATED CARCINOMA OF UNKNOWN PRIMARY SITE [J].
VANDERGAAST, A ;
VERWEIJ, J ;
PLANTING, AST ;
HOP, WCJ ;
STOTER, G .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (07) :1720-1725
[30]  
Webb WR, 2001, HIGH RESOLUTION CT L, P267